Mark Erlander | executive |
James Levine | executive |
Marc Frahm | analyst |
Joseph Catanzaro | analyst |
Tsan-Yu Hsieh | analyst |
Welcome to the Cardiff Oncology First Quarter 2024 Financial Results and Business Update Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to turn the conference over to Kiki Patel of Gilmartin Group. Please go ahead.
Thank you, operator.
Joining us on the call today from Cardiff Oncology are Chief Executive Officer, Mark Erlander; and Chief Financial Officer, Jamie Levine.